Pliant Therapeutics Incorporated
At Pliant, we are committed to advancing novel treatments aimed at changing the fibrosis treatment landscape.
Pliant's Chief Medical Officer Discusses INTEGRIS-IPF Phase 2a Data
Greg's Journey: From the Pulmonary Fibrosis Foundation to Pliant
Pliant and the Pulmonary Fibrosis Foundation: A Committed Partnership with a Shared Vision
September is Pulmonary Fibrosis Awareness Month
Pliant's Approach: The Role of Integrins in Fibrosis
Pliant's Approach: The TGF-β Fibrosis Cascade
Pliant's Approach: PLN-74809 – Pliant’s Tissue-Specific Approach to Treating Fibrosis
A Discussion on Pulmonary Fibrosis: A Physician's Perspective